Constellation Brands (STZ) delivered an earnings beat Friday, along with a compelling outlook that prompted us to raise our price target on shares of the Corona brewer.
Excluding equity losses from Constellation's stake in cannabis company Canopy , adjusted earnings came in at $3.04 per share.
Bottom line Management's full-year guidance — like the headline sales and earnings numbers — was better than the estimates from Wall Street.
Company results Beer sales of $2.1 billion, up 11% year over year, were better than analysts' expectations of $2.07 billion.
Taking out capital expenditures of $1.2 billion to $1.3 billion (unchanged), the free cash flow forecast comes in between $1.2 billion and $1.3 billion (unchanged).
Persons:
—, we're, That's, depletions, Jim Cramer's, Jim Cramer, Jim, Daniel Acker
Organizations:
Constellation Brands, Corona, Refinitiv, Wall, Modelo Especial, Wall Street, Management, CNBC, Constellation Brands Inc, Bloomberg, Getty
Locations:
U.S, Ottawa , Illinois